ArticlePharmacology research & perspectives2025

Preclinical Evaluation of the Oral Toxicity, Genotoxicity, and Safety Pharmacology of LPM4870108, a Novel Potent Tropomyosin Receptor Kinase Inhibitor.

Xiaochen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.